Unspecific activation of caspases during the induction of apoptosis by didemnin B in human cell lines

Journal of Cellular Biochemistry

Volumn 72, Issue 2, 1999, Pages 269-278

  Johnson, Karina L ^a   Grubb, David R ^a   Lawen, Alfons ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Caspase 1; Caspase 3; Daudi; HL 60; Poly(ADP ribose)polymerase; Roscovitine

Indexed keywords

ACETYLASPARTYLGLUTAMYLVALYLASPARTIC ACID ALDEHYDE; ACETYLTYROSYLVALYLALANYLASPARTIC ACID CHLOROMETHYLKETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTIC ACID FLUOROMETHYLKETONE; CASPASE 3; CASPASE INHIBITOR; DIDEMNIN B; INTERLEUKIN 1BETA CONVERTING ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ROSCOVITINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DAUDI CELL; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CASPASE 1; CASPASE 3; CASPASES; CELL LINE; DEPSIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; HL-60 CELLS; HUMANS; IMMUNOBLOTTING; OLIGOPEPTIDES; PEPTIDES, CYCLIC; POLY(ADP-RIBOSE) POLYMERASES; PURINES; TIME FACTORS;

EID: 0033555259     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990201)72:2<269::AID-JCB11>3.0.CO;2-D     Document Type: Article

References (23)

1. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, and Yuan J. 1996. Human ICE/CED-3 protease nomenclature. Cell 87:171.
2. Armstrong RC, Aja T, Xiang J, Gaur S, Krebs JF, Hoang K, Bai X, Korsmeyer SJ, Karanewsky DS, Fritz LC, Tomaselli KJ. 1996. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem 271:16850-16855.
3. Crampton SL, Adams EG, Kuentzel SL, Li LH, Badiner G, Bhuyan BK. 1984. Biochemical and cellular effects of didemnins A and B. Cancer Res 44:1796-1801.
4. Darmon AJ, Bleackley RC. 1996. An interleukin-1β converting enzyme-like protease is a key component of Fas-mediated apoptosis. J Biol Chem 271:21699-21702.
5. Enari M, Talanian RV, Wong WW, Nagata S. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723-726.
6. Fernandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L, Tomaselli KJ, Wang L, Yu Z, Croce CM, Salveson G, Earnshaw WC, Litwack G, Alnemri ES. 1995. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 55:6045-6052.
7. Grubb DR, Wolvetang EJ, Lawen A. 1995. Didemnin B induces cell death by apoptosis: The fastest induction of apoptosis ever described. Biochem Biophys Res Commun 215:1130-1136.
8. Johnson KL, Vaillant F, Lawen A. 1996. Protein tyrosine kinase inhibitors prevent didemnin B-induced apoptosis in HL-60 cells. FEBS Lett 383:1-5.
9. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. 1993. Specific proteolytic cleavage of poly-(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976-3985.
10. Margolin N, Raybuck SA, Wilson KP, Chen W, Fox T, Gu Y, Livingston DJ. 1997. Substrate and inhibitor specificity of interleukin-1β-converting enzyme and related caspases. J Biol Chem 272:7223-7228.
11. McCarthy NJ, Whyte MKB, Gilbert CS, Evan GI. 1997. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol 136:215-227.
12. Meijer L, Borgne A, Mulner O, Chong JPJ, Blow JJ, Inagaki N, Inagaki M, Delcros J-G, Moulinoux J-P. 1997. Biochemical and cellular effects of roscovitine, a potent and-selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243:527-536.
13. Meijer L, Kim SH. 1997. Chemical inhibitors of cyclin-dependent kinases. Methods Enzymol 283:113-128.
14. Monney L, Otter I, Olivier R, Ozer HL, Haas AL, Omura S, Borner C. 1998. Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2. J Biol Chem 273:6121-6131.
15. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T, Yu VL, Miller DK. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
16. Porter AG, Ng P, Jänicke RU. 1997. Death substrates come alive. BioEssays 19:501-507.
17. Shin DM, Holoye PY, Forman A, Winn R, Perez-Soler R, Dakhil S, Rosenthal J, Raber MN, Hong WK. 1994. Phase II clinical trial of didemnin B in previously treated small cell lung cancer. Invest New Drugs 12:243-249.
18. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJ-F, Egger LA, Gaffney EP, Limjuco G, Payha OC, Raju SM, Rolando AM, Salley JP, Yamin T, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ. 1992. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356:768-774.
19. Wang X, Zelenski NG, Yang J, Sakai J, Brown MS, Goldstein JL. 1996. Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J 15:1012-1020.
20. Wilson KP, Black JF, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck SA, Livingston DJ. 1994. Structure and mechanism of interleukin-1β converting enzyme. Nature 370:270-275.
21. Xiang J, Chao DT, Korsmeyer SJ. 1996. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc Natl Acad Sci USA 93:14559-14563.
22. Yuan J, Horvitz HR. 1990. The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death. Dev Biol 138:33-41.
23. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. 1993. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75:641-652.